FEATURES OF BONE METABOLISM IN PATIENTS WITH DIABETIC OSTEOARTHROPATHY OF VARIOUS STAGES
##plugins.themes.academic_pro.article.sidebar##
Downloads
##plugins.themes.academic_pro.article.main##
Abstract
In this article, the authors studied the features of bone metabolism in 67 patients with type 2 diabetes and with diabetic osteoarthropathy of various stages. The levels of 25-hydroxyvitamin D 3 were significantly lower in patients of all 4 x groups (average age 70 ± 12 years) than in the control group (27.2 ± 6.2 ng / ml).
It should be noted that 34 (50.7%) of patients with diabetic pope ulcers had a severe deficiency of 25-hydroxyvitamin D 3 with levels below 10 ng / ml.
Only 13% of patients, the level of 25-hydroxyvitamin D 3 exceeded 20 ng / ml. In addition, secondary hyperparathyroidism was found in 26% of patients, and at 12.5% of patients a hypocalcemia was revealed.
A negative correlation was established (R = -0.241) (p <00,1) between the classification of Armstrong and the status of 25-hydroxyvitamin D 3.
The authors concluded that patients with diabetic foot syndrome complicated by Stop Charcot are susceptible to high risk of 25-hydroxyvitamin d3 and calcium deficiency. Any patient with the diabetic foot syndrome should take measurement of the level of 25-hydroxyvitamin D 3 and obtain prophylactic treatment when reduced indicators are detected.
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Vestergaard P., Rejnmark L., Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48:1292–1299. doi: 10.1007/s00125-005-1786-3. [PubMed] [CrossRef] [Google Scholar]
- Retzepi M., Donos N. The effect of diabetes mellitus on osseous healing. Clin. Oral Implants Res. 2010;21:673–681. doi: 10.1111/j.1600-0501.2010.01923.x. [PubMed] [CrossRef] [Google Scholar]
- Hernandez R.K., Do T.P., Critchlow C.W., Dent R.E., Jick S.S. Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthop. 2012;83:653–660. doi: 10.3109/17453674.2012.747054. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
- Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos. Int. 2007;18:427–444. doi: 10.1007/s00198-006-0253-4. [PubMed] [CrossRef] [Google Scholar]
- Picke A.K., Campbell G., Napoli N., Hofbauer L.C., Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocrinol. Connect. 2019;8:R55–R70. doi: 10.1530/EC-18-0456. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
- Lauterbach S., Kostev K., Kohlmann T. Prevalence of diabetic foot syndrome and its risk factors in the UK. J. Wound Care. 2010;19:333–337. doi: 10.12968/jowc.2010.19.8.77711. [PubMed] [CrossRef] [Google Scholar]
- Pscherer S., Dippel F.W., Lauterbach S., Kostev K. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes. 2012;6:241–246. doi: 10.1016/j.pcd.2012.02.004. [PubMed] [CrossRef] [Google Scholar]
- Kahm K., Laxy M., Schneider U., Rogowski W.H., Lhachimi S.K., Holle R. Health care costs associated with incident complications in patients with type 2 diabetes in Germany. Diabetes Care. 2018;41:971–978. doi: 10.2337/dc17-1763. [PubMed] [CrossRef] [Google Scholar]
- Prasad R.B., Groop L. Precision medicine in type 2 diabetes. J. Intern Med. 2019;285:40–48. doi: 10.1111/joim.12859. [PubMed] [CrossRef] [Google Scholar]
- Ehnert S., Rinderknecht H., Aspera-Werz R.H., Haussling V., Nussler A.K. Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: Challenges of complex models. Arch. Toxicol. 2020;94:3937–3958. doi: 10.1007/s00204-020-02906-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]